                         Listagem de Sequncias

<110>  Instituto Butantan
 
<120>  COMPOSTO, USO, COMPOSIO FARMACUTICA, MTODO DE 
       DIAGNSTICO, MTODO DE TRATAMENTO E MTODO DE CARREAMENTO
       E/OU INTERNALIZAO DE UM COMPOSTO PARA DENTRO DE CLULAS 
       EUCARITICAS

<130>  000000000

<150>  BR 102018074037-7
<151>  22/11/2018

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  50
<212>  PRT
<213>  Sequncia Artificial

<220>
<223>  Cter

<400>  1

Glu Glu Gln Thr His Phe His Phe Glu Ser Pro Lys Leu Ile Ser Phe 
1               5                   10                  15      


Lys Val Gln Asp Tyr Trp Ile Leu Asn Asp Ile Met Lys Lys Asn Leu 
            20                  25                  30          


Thr Gly Ile Ser Leu Lys Ser Glu Glu Glu Asp Ala Asp Ser Gly Glu 
        35                  40                  45              


Ile Asp 
    50  


<210>  2
<211>  11
<212>  PRT
<213>  Sequncia Artificial

<220>
<223>  P4

<400>  2

Tyr Ala Ile Gly Tyr Ser Ser Lys Asp Tyr Lys 
1               5                   10      


<210>  3
<211>  61
<212>  PRT
<213>  Sequncia Artificial

<220>
<223>  P4-Cter

<400>  3

Tyr Ala Ile Gly Tyr Ser Ser Lys Asp Tyr Lys Glu Glu Gln Thr His 
1               5                   10                  15      


Phe His Phe Glu Ser Pro Lys Leu Ile Ser Phe Lys Val Gln Asp Tyr 
            20                  25                  30          


Trp Ile Leu Asn Asp Ile Met Lys Lys Asn Leu Thr Gly Ile Ser Leu 
        35                  40                  45              


Lys Ser Glu Glu Glu Asp Ala Asp Ser Gly Glu Ile Asp 
    50                  55                  60      


<210>  4
<211>  11
<212>  PRT
<213>  Sequncia Artificial

<220>
<223>  P15

<400>  4

Cys Trp Met Ser Pro Arg His Leu Gly Thr Cys 
1               5                   10      


<210>  5
<211>  61
<212>  PRT
<213>  Sequncia Artificial

<220>
<223>  Cter-P15

<400>  5

Cys Trp Met Ser Pro Arg His Leu Gly Thr Cys Glu Glu Gln Thr His 
1               5                   10                  15      


Phe His Phe Glu Ser Pro Lys Leu Ile Ser Phe Lys Val Gln Asp Tyr 
            20                  25                  30          


Trp Ile Leu Asn Asp Ile Met Lys Lys Asn Leu Thr Gly Ile Ser Leu 
        35                  40                  45              


Lys Ser Glu Glu Glu Asp Ala Asp Ser Gly Glu Ile Asp 
    50                  55                  60      


<210>  6
<211>  20
<212>  PRT
<213>  Sequncia Artificial

<220>
<223>  F1C

<400>  6

Glu Glu Gln Thr His Phe His Phe Glu Ser Pro Lys Leu Ile Cys Phe 
1               5                   10                  15      


Lys Val Gln Asp 
            20  


<210>  7
<211>  20
<212>  PRT
<213>  Sequncia Artificial

<220>
<223>  F2C

<400>  7

Phe Lys Val Gln Asp Tyr Trp Ile Leu Asn Asp Ile Met Lys Lys Asn 
1               5                   10                  15      


Leu Thr Gly Ile 
            20  


<210>  8
<211>  20
<212>  PRT
<213>  Sequncia Artificial

<220>
<223>  F3C

<400>  8

Asn Leu Thr Gly Ile Ser Leu Lys Ser Glu Glu Glu Asp Ala Asp Ser 
1               5                   10                  15      


Gly Glu Ile Asp 
            20  


